Healthcare

Cholesterol Test Market Forecast 2024-2033: Growth Rate, Drivers, And Trends

The Cholesterol Test Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Cholesterol Test Market:

https://www.thebusinessresearchcompany.com/report/cholesterol-test-global-market-report

According to The Business Research Company’s Cholesterol Test Global Market Report 2024, The cholesterol test market size has grown strongly in recent years. It will grow from $8.31 billion in 2023 to $9.1 billion in 2024 at a compound annual growth rate (CAGR) of 9.6%. The growth in the historic period can be attributed to cardiovascular disease awareness, research on heart health, public health campaigns, physician recommendations, patient education.

The cholesterol test market size is expected to see strong growth in the next few years. It will grow to $12.61 billion in 2028 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to integration in corporate wellness, precision nutrition influence, health conscious consumerism, genetic testing integration, personalized medicine shift. Major trends in the forecast period include cholesterol-targeted therapies, integration with health apps, cholesterol education platforms, comprehensive lipid panels, point-of-care testing expansion.

The rise in the prevalence of cardiovascular diseases is expected to propel the growth of the cholesterol test market. Cardiovascular diseases (CVDs) are a category of heart and blood vessel disorders, including coronary heart disease, stroke, peripheral arterial disease, aortic disease, and other conditions. A cholesterol test provides individuals and doctors with vital information about the chance of developing heart disease. For instance, in April 2023, according to the World Heart Federation, over 500 million individuals worldwide will remain impacted by cardiovascular diseases. These conditions led to 20.5 million fatalities in 2021, representing nearly one-third of the total global mortality and reflecting a notable rise from the previously estimated 121 million deaths attributed to cardiovascular diseases. Therefore, rising death and the prevalence of cardiovascular diseases will drive the cholesterol test market.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample.aspx?id=11968&type=smp

The cholesterol test market covered in this report is segmented –

1) By Product Type: Test Kits, Test Strips, Other Product Types

2) By Test Type: Total Cholesterol Test, High-Density Lipoprotein (HDL) Cholesterol, Low-Density Lipoprotein (LDL) Cholesterol, Triglycerides or Very Low-Density Lipoprotein (VLDL) Cholesterol Test

3) By Distribution Channel: Over the Counter, Prescription Based

4) By End User: Hospitals, Diagnostic Centers, Other End-Users

Technological advancement is a key trend gaining popularity in the cholesterol test market. Major companies and research institutes focus on developing innovative solutions for cheaper, more efficient, and advanced cholesterol testing. For instance, in November 2022, Ural Federal University (UrFU), a Russia-based education and research institute, introduced a microfluidic chip, a sensor device for measuring blood cholesterol levels, where all system elements are integrated, is printed on a 3D printer. The new technique used in the sensor requires a minimal volume of blood to identify cholesterol levels, where blood is placed in an analyzing chip containing an acetonitrile-based copper chloride solution. This chip includes an electrode connected to a voltametric analyzer, which provides the analysis results quicker using magnetic nanoparticles with polymers with molecular imprints that preferentially absorb cholesterol that filter out other blood elements necessary for blood composition.

The cholesterol test market report table of contents includes: